OptiKira
Cleveland
About OptiKira
OptiKira develops novel therapeutics intended to prevent cell death. It targets UPR and regulates its activity to prevent cell degeneration in idiopathic pulmonary fibrosis, nonalcoholic steatohepatitis, diabetes, cancer,, and various neurodegenerative diseases, enabling medical practitioners to treat Retinitis pigmentosa, amyotrophic lateral sclerosis, and other chronic diseases. OptiKira was founded in 2014 and is headquartered in Cleveland, Ohio.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $8.2M
- Last round: Grant (May 2019)
- Website: optikira.com
- Phone: (216)455-3216
Industries & Categories
Eyewear, Health Care, Medical, Therapeutics
Canonical: https://fsome.com/organization/optikira-4363 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.